InVivo Therapeutics Holdings Quick Ratio 2010-2023 | NVIVQ
Historical quick ratio values for InVivo Therapeutics Holdings (NVIVQ) over the last 10 years.
| InVivo Therapeutics Holdings Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2023-09-30 | $0.00B | $0.00B | 0.00 |
| 2023-06-30 | $0.00B | $0.00B | 0.00 |
| 2023-03-31 | $0.00B | $0.00B | 0.00 |
| 2022-12-31 | $0.00B | $0.00B | 0.00 |
| 2022-09-30 | $0.00B | $0.00B | 0.00 |
| 2022-06-30 | $0.00B | $0.00B | 0.00 |
| 2022-03-31 | $0.00B | $0.00B | 0.00 |
| 2021-12-31 | $0.00B | $0.00B | 0.00 |
| 2021-09-30 | $0.00B | $0.00B | 0.00 |
| 2021-06-30 | $0.00B | $0.00B | 0.00 |
| 2021-03-31 | $0.00B | $0.00B | 0.00 |
| 2020-12-31 | $0.00B | $0.00B | 0.00 |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.00B | $0.00B | 0.00 |
| 2019-09-30 | $0.00B | $0.00B | 0.00 |
| 2019-06-30 | $0.00B | $0.00B | 0.00 |
| 2019-03-31 | $0.00B | $0.00B | 0.00 |
| 2018-12-31 | $0.00B | $0.00B | 0.00 |
| 2018-09-30 | $0.00B | $0.00B | 0.00 |
| 2018-06-30 | $0.00B | $0.03B | 0.00 |
| 2018-03-31 | $0.00B | $0.00B | 0.00 |
| 2017-12-31 | $0.00B | $0.00B | 0.00 |
| 2017-09-30 | $0.00B | $0.00B | 0.00 |
| 2017-06-30 | $0.00B | $0.00B | 0.00 |
| 2017-03-31 | $0.00B | $0.00B | 0.00 |
| 2016-12-31 | $0.00B | $0.01B | 0.00 |
| 2016-09-30 | $0.00B | $0.01B | 0.00 |
| 2016-06-30 | $0.00B | $0.01B | 0.00 |
| 2016-03-31 | $0.00B | $0.01B | 0.00 |
| 2015-12-31 | $0.00B | $0.00B | 0.00 |
| 2015-09-30 | $0.00B | $0.01B | 0.00 |
| 2015-06-30 | $0.00B | $0.01B | 0.00 |
| 2015-03-31 | $0.00B | $0.02B | 0.00 |
| 2014-12-31 | $0.00B | $0.01B | 0.00 |
| 2014-09-30 | $0.00B | $0.01B | 0.00 |
| 2014-06-30 | $0.00B | $0.01B | 0.00 |
| 2014-03-31 | $0.00B | $0.00B | 0.00 |
| 2013-12-31 | $0.00B | $0.00B | 0.00 |
| 2013-09-30 | $0.00B | $0.00B | 0.00 |
| 2013-06-30 | $0.00B | $0.00B | 0.00 |
| 2013-03-31 | $0.00B | $0.03B | 0.00 |
| 2012-12-31 | $0.00B | $0.02B | 0.00 |
| 2012-09-30 | $0.00B | $0.01B | 0.00 |
| 2012-06-30 | $0.00B | $0.03B | 0.00 |
| 2012-03-31 | $0.00B | $0.03B | 0.00 |
| 2011-12-31 | $0.00B | $0.04B | 0.00 |
| 2011-09-30 | $0.00B | $0.01B | 0.00 |
| 2011-06-30 | $0.00B | $0.01B | 0.00 |
| 2011-03-31 | $0.00B | $0.01B | 0.00 |
| 2010-12-31 | $0.00B | $0.01B | 0.00 |
| 2010-09-30 | $0.00B | $0.00B | 0.00 |
| 2010-06-30 | $0.00B | $0.00B | 0.00 |
| 2010-03-31 | $0.00B | $0.00B | 0.00 |
| 2009-12-31 | $0.00B | 0.00 | |
| 2009-09-30 | $0.00B | $0.00B | 0.00 |
| 2009-06-30 | $0.00B | $0.00B | 0.00 |
| 2009-03-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.001B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.664B | 26.43 |
| Stryker (SYK) | United States | $141.745B | 33.12 |
| Boston Scientific (BSX) | United States | $122.979B | 37.45 |
| Medtronic (MDT) | Ireland | $115.565B | 17.20 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.437B | 35.40 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.258B | 0.00 |
| ResMed (RMD) | United States | $36.993B | 32.57 |
| Koninklijke Philips (PHG) | Netherlands | $29.119B | 22.13 |
| Terumo (TRUMY) | Japan | $27.757B | 39.20 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.878B | 13.77 |
| Baxter (BAX) | United States | $20.540B | 13.93 |
| Insulet (PODD) | United States | $16.399B | 68.99 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.775B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.205B | 30.50 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.646B | 32.33 |
| Lantheus Holdings (LNTH) | United States | $7.464B | 17.92 |
| ICU Medical (ICUI) | United States | $4.385B | 41.84 |
| Haemonetics (HAE) | United States | $3.926B | 19.42 |
| TG Therapeutics (TGTX) | United States | $3.854B | 40.80 |
| Perrigo (PRGO) | Ireland | $3.848B | 12.16 |
| GN Store Nord (GNNDY) | Denmark | $3.656B | 22.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.651B | 18.19 |
| Neogen (NEOG) | United States | $3.541B | 37.14 |
| Envista Holdings (NVST) | United States | $3.248B | 17.33 |
| QuidelOrtho (QDEL) | United States | $3.092B | 19.49 |
| Agios Pharmaceuticals (AGIO) | United States | $2.584B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.305B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.294B | 38.50 |
| LeMaitre Vascular (LMAT) | United States | $2.022B | 53.89 |
| AdaptHealth (AHCO) | United States | $1.537B | 11.10 |
| Warby Parker (WRBY) | United States | $1.510B | 0.00 |
| InMode (INMD) | Israel | $1.433B | 9.12 |
| AtriCure (ATRC) | United States | $1.329B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.175B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.157B | 0.00 |
| Evolus (EOLS) | United States | $1.058B | 0.00 |
| PetIQ (PETQ) | United States | $0.918B | 23.28 |
| Phibro Animal Health (PAHC) | United States | $0.872B | 18.09 |
| National Vision Holdings (EYE) | United States | $0.848B | 26.95 |
| Cresco Labs (CRLBF) | United States | $0.830B | 0.00 |
| Surmodics (SRDX) | United States | $0.563B | 119.51 |
| Quanterix (QTRX) | United States | $0.498B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.472B | 14.23 |
| ZimVie (ZIMV) | United States | $0.462B | 42.95 |
| Valneva SE (VALN) | France | $0.438B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.418B | 0.00 |
| Jin Medical (ZJYL) | China | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.382B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.341B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.328B | 8.46 |
| Aurora Cannabis (ACB) | Canada | $0.323B | 0.00 |
| Biote (BTMD) | United States | $0.320B | 14.77 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 30.96 |
| Zynex (ZYXI) | United States | $0.253B | 44.28 |
| Ayr Wellness (AYRWF) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.234B | 15.56 |
| Omeros (OMER) | United States | $0.226B | 0.00 |
| MacroGenics (MGNX) | United States | $0.215B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.176B | 73.00 |
| FitLife Brands (FTLF) | United States | $0.150B | 20.26 |
| Capricor Therapeutics (CAPR) | United States | $0.144B | 0.00 |
| Brainsway (BWAY) | Israel | $0.141B | 168.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.119B | 0.00 |
| Veru (VERU) | United States | $0.119B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Fonar (FONR) | United States | $0.109B | 11.01 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
| InterCure (INCR) | Israel | $0.087B | 14.69 |
| Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.075B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| MariMed (MRMD) | United States | $0.064B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.58 |
| Exagen (XGN) | United States | $0.051B | 0.00 |
| Bright Green (BGXX) | United States | $0.037B | 0.00 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.037B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.027B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Agape ATP (ATPC) | $0.009B | 0.00 | |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 21.14 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |